Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Footer now includes Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T18:56:09.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Publications description updated to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the page revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T07:35:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Administrative funding status notice was removed from the page. The rest of the study details, eligibility criteria, and intervention descriptions remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-19T08:23:56.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The new screenshot shows minor formatting and wording adjustments across the page; core trial details, arms, outcomes, and listed locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:26:29.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    - Added a government funding and operating-status notice and updated the version to v3.2.0. - Removed the specific resource topic “Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus” and downgraded the revision from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T16:08:04.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:10:52.000Z thumbnail image

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.